{
    "eid": "2-s2.0-85073422518",
    "title": "Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer\u2019s disease and vascular dementia",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Alzheimer\u2019s disease",
        "Concomitant drugs treatment",
        "CYP2D6 polymorphisms",
        "Donepezil",
        "Vascular dementia"
    ],
    "authors": [
        "Thitipon Yaowaluk",
        "Vorapun Senanarong",
        "Chanin Limwongse",
        "Rasda Boonprasert",
        "Pornpimol Kijsanayotin"
    ],
    "citedby-count": 13,
    "ref-count": 46,
    "ref-list": [
        "Alzheimer\u2019s disease",
        "Global prevalence of dementia: A Delphi consensus study",
        "Donepezil for dementia due to Alzheimer\u2019s disease",
        "Donepezil for vascular cognitive impairment",
        "Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer\u2019s disease",
        "Donepezil in Alzheimer\u2019s disease: Fromconventional trials to pharmacogenetics",
        "Stereoselective metabolism of donepezil and steady-state plasma concentrations of S-donepezil based on CYP2D6 polymorphisms in the therapeutic responses of Han Chinese patients with Alzheimer\u2019s disease",
        "Cognitive predictors of donepezil therapy response in Alzheimer disease",
        "Opportunities in pharmacogenomics for the treatment of Alzheimer\u2019s disease",
        "Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors",
        "Donepezil inhibits the amyloidbeta oligomer-induced microglial activation in vitro and in vivo",
        "Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment?",
        "Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I",
        "Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease",
        "Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer\u2019s disease patients",
        "Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with alzheimer\u2019s disease",
        "Influence of the rs1080985 single nucleotide polymorphism of the CYP2D6 gene and APOE polymorphism on the response to donepezil treatment in patients with Alzheimer\u2019s disease in China",
        "Combination of multiplex PCR and DHPLC-based strategy for CYP2D6 genotyping scheme in Thais",
        "Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy",
        "Clinical practice with antidementia drugs in a geriatric clinic",
        "Thai mental state examination (TMSE)",
        "Apolipoprotein E gene polymorphism: Effects on plasma lipids and risk of type 2 diabetes and coronary artery disease",
        "Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer\u2019s disease",
        "Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/ tandem mass spectrometry: Application to a pharmacokinetic study",
        "Implementation of a cost-effective HPLC/UV-approach for medical routine quantification of donepezil in human serum",
        "Effect of CYP2D6*10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer\u2019s disease",
        "CYP2D6 genotype analysis of a Thai population: Platform comparison",
        "Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population",
        "CYP2D6 polymorphisms and the impact on tamoxifen therapy",
        "Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer\u2019s disease",
        "Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: Assessment of pharmacokinetic changes and safety following single and multiple oral doses",
        "Inhibitory effects of memantine on human cytochrome P450 activities: Prediction of in vivo drug interactions",
        "CYP2D6 variation, behaviour and psychopathology:Implications for pharmacogenomics-guided clinical trials",
        "Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer\u2019s disease following chronic donepezil treatment",
        "Pathology and pathogenesis of vascular cognitive impairment-a critical update",
        "CYP2D6 in the brain:Genotype effects on resting brain perfusion",
        "Clinical response to donepezil in mild and moderate dementia: Relationship to drug plasma concentration and CYP2D6 and APOE genetic polymorphisms",
        "Effect of the CYP2D6 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer\u2019s disease: A systematic review and meta-analysis",
        "Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance",
        "Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients",
        "Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer\u2019s disease cohort",
        "Potential drug-drug interactions in Alzheimer patients with behavioral symptoms",
        "Donepezil attenuates Abetaassociated mitochondrial dysfunction and reduces mitochondrial Abeta accumulation in vivo and in vitro",
        "Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations",
        "Apolipoprotein E4 frequencies in a Japanese population with Alzheimer\u2019s disease and dementia with Lewy bodies"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Health Research and Development",
        "International College Mahidol University",
        "Srinakharinwirot University",
        "Chulalongkorn University",
        "Mahidol University"
    ]
}